Lixte Biotechnology Holdings Inc.

(LIXT)

By |

Profile

Lixte Biotech Holdings Inc is US-based drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which better therapies are urgently needed. It mainly designs drugs for which there are existing data suggesting any effect to altered pathways of the cancer cell and may be given safely to humans. The development program of the company includes drugs for the treatment of cancer, consisting of protein phosphatase inhibitors and histone deacetylase inhibitors.

Contact Information

Website: www.lixte.com
Main Phone: +1 631 942-7959
Address: 248 Route 25A, No. 2
State: NY
City / Town: East Setauket
Country: USA
Postal Code: 11733

Issuer Information

Exchange: OTCQB
CEO: John S. Kovach
Employees: 1
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.95 $ 0.05 (5.56%)
Last Price 0.95 Change $ 0.05 Change % 5.56 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.95 High 0.95 Low 0.95 Prev Close 0.90
Last Trade Volume 617 52 Wk Hi 1.84 52 Wk Low 0.12
Market Cap 55.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 58,045,814.00 EPS (TTM) -0.05 PE Ratio N/A Exchange OTCQB